Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risk of Posterior Staphyloma in Highly Myopic Europeans
NCT06949579Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Feb 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Trial (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoints: Identification of genetic variants (SNPs) significantly associated with the presence of posterior staphyloma at 1 year and Differential gene expression between myopic patients with and without staphyloma at 1 year. Started Feb 2026; status: recruiting.
Beyond the preview
Go deeper on NCT06949579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06949579.